Skip to main content

Table 5 Frequency of each criterion of MS according to ATP III and IDF in men with and without clinical lipodystrophy

From: Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients

Men

ATPIII

IDF

MS criteria

Total

Without CL

With CL

p value

Total

Without CL

With CL

p value

WC [n, (%)]

43 (18.0%)

21 (24.7%)

22 (14.3%)

0.045

98 (41.0%)

42 (49.4%)

56 (36.4%)

0.050

TG [n, (%)]

197 (82.4%)

65 (76.5%)

132 (85.7%)

0.072

197 (82.4%)

65 (76.5%)

132 (85.7%)

0.072

HDL [n, (%)]

181 (75.7%)

62 (72.9%)

119 (77.3%)

0.455

181 (75.7%)

62 (72.9%)

119 (77.3%)

0.455

BP [n, (%)]

111 (46.6%)

41 (48.2%)

70 (45.8%)

0.713

111 (46.6%)

41 (48.2%)

70 (45.8%)

0.713

GLU [n, (%)]

107 (44.8%)

35 (41.2%)

72 (46.8%)

0.407

103 (43.1%)

35 (41.2%)

68 (44.2%)

0.656

Number of MS criteria

        

0

8 (3.3)

3 (3.5)

5 (3.3)

 

8 (3.4)

3 (3.5)

5 (3.3)

 

1

29 (12.1)

15 (17.6)

14 (9.2)

 

24 (10.1)

11 (12.9)

13 (8.5)

 

2

72 (30.1)

21 (24.7)

51 (33.3)

 

60 (25.29

19 (22.4)

41 (26.8)

 

3

67 (28.5)

23 (27.1)

44 (28.8)

 

70 (29.4)

22 (25.9)

48 (31.4)

 

4

48 (20.1)

17 (20.0)

31 (20.3)

 

48 (20.2)

20 (23.5)

28 (18.3)

 

5

14 (5.9)

6 (7.1)

8 (5.2)

0.411

28 (11.8)

10 (11.8)

18 (11.8)

0.718

  1. Note - CL = Clinical lipodystrophy MS = Metabolic syndrome; ATPIII = Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults; IDF = International Diabetes Federation; WC = waist circumference; TG = triglycerides; HDL = HDL cholesterol; BP = blood pressure; GLU = glucose.